ARK Genomic Revolution ETF Rating $47.64 -2.23 (-4.47%) As of 08/28/2026 04:10 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartHoldingsNews and TrendsOwnershipRatingsShort Interest ARK Genomic Revolution ETF Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.ARKG Aggregate RatingModerate Buy 2.58Holdings in ARKG have an aggregate rating of Moderate Buy based on 341 analyst ratings issued in the past year covering 25 companies (94.9% of the portfolio).ARKG Aggregate Price Target$47.64High Prediction$47.64Average Prediction$47.64Low Prediction$47.64Holdings in ARKG have an aggregate price target of $47.64 and a range of $47.64 to $47.64 covering 25 companies (94.9% of the portfolio).ARKG Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy0 Buy rating(s)Moderate Buy16 Moderate Buy rating(s)Hold9 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by ARK Genomic Revolution ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 ARKG Holdings ExportWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings10.03%TXG10x Genomics$61.54-5.1%1.499 of 5 stars2.25$38.31 -37.8%16Insider Trade9.19%TWSTTwist Bioscience$141.38-7.7%1.6717 of 5 stars2.70$98.30 -30.5%10Positive NewsInsider Trade7.09%TEMTempus AI$64.04-9.4%2.1232 of 5 stars2.41$65.69 2.6%17Analyst DowngradeInsider TradeGap Down6.17%CRSPCRISPR Therapeutics$57.72-2.8%2.3114 of 5 stars2.61$68.06 17.9%18Analyst Forecast5.46%ABSIAbsci$8.71-7.5%2.8783 of 5 stars2.78$13.43 54.2%9Positive NewsGap Down5.44%PSNLPersonalis$17.07+1.6%1.5803 of 5 stars2.20$14.54 -14.8%104.30%LLYEli Lilly and Company$1,168.98-0.6%4.8783 of 5 stars2.83$1,292.18 10.5%30Trending NewsAnalyst Upgrade4.18%NTRANatera$326.26-3.7%2.4866 of 5 stars2.82$319.38 -2.1%22News CoveragePositive NewsInsider Trade4.08%GHGuardant Health$161.50-4.2%3.1195 of 5 stars2.96$183.78 13.8%25Positive NewsAnalyst ForecastOptions Volume4.07%CDNACareDx$49.79-4.9%3.339 of 5 stars2.57$47.75 -4.1%7News CoveragePositive News3.89%ILMNIllumina$215.59-5.3%2.5288 of 5 stars2.47$188.40 -12.6%17Trending NewsInsider Trade3.43%BEAMBeam Therapeutics$29.32-3.8%2.0934 of 5 stars2.69$49.00 67.1%13News CoveragePositive NewsAnalyst ForecastGap Down3.33%CMPSCompass Pathways$13.73-6.2%2.5615 of 5 stars2.88$23.36 70.1%17Positive NewsOptions Volume2.56%NRIXNurix Therapeutics$26.21-2.5%3.1805 of 5 stars2.80$34.21 30.5%15Positive News2.53%RXRXRecursion Pharmaceuticals$3.34-2.9%1.8819 of 5 stars2.20$8.06 141.3%5Analyst UpgradeOptions Volume2.43%ADPTAdaptive Biotechnologies$25.19-4.7%1.6887 of 5 stars2.57$24.42 -3.1%7Positive News2.37%BFLYButterfly Network$8.48-2.8%1.2544 of 5 stars2.40$5.56 -34.4%5Positive News2.25%SDGRSchrodinger$19.70-3.5%1.3084 of 5 stars2.29$20.50 4.1%7Positive NewsAnalyst Upgrade2.22%WGSGeneDx$86.33-3.3%2.5196 of 5 stars2.89$89.57 3.8%9Positive NewsAnalyst Upgrade2.04%VCYTVeracyte$43.34-4.2%4.4963 of 5 stars2.82$54.33 25.4%11News CoveragePositive News1.82%NTLAIntellia Therapeutics$12.87-1.8%3.0167 of 5 stars2.35$21.15 64.4%23Positive NewsAnalyst Forecast1.77%ALMRAlamar Biosciences$30.71-6.9%1.8252 of 5 stars2.43$31.80 3.5%71.67%IONSIonis Pharmaceuticals$61.05-2.2%3.8192 of 5 stars2.73$94.15 54.2%22News CoveragePositive NewsGap Down1.34%PRMEPrime Medicine$3.61-0.8%2.7475 of 5 stars2.89$7.47 107.0%9News CoverageAnalyst Forecast1.21%ARCTArcturus Therapeutics$15.19-6.1%2.2492 of 5 stars2.60$20.00 31.7%10Gap Down This page (BATS:ARKG) was last updated on 8/30/2026 by MarketBeat.com Staff. From Our PartnersThe retirement stock I'd buy before Nvidia todayIn 2014, Marc Chaikin pointed readers toward Nvidia. Now the 60-year Wall Street veteran and creator of the Ch...Chaikin Analytics | SponsoredYour $29.97 book is free todayWhy Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...Profits Run | SponsoredThe cat is out the bagAlmost 80,000 tech jobs vanished in the first three months of 2026. Meta cut 14,000 roles, Microsoft offered s...Porter & Company | SponsoredA “bloodbath” Is ComingReports suggest some Silicon Valley billionaires are stockpiling gold, guns, and gas masks - or leaving the co...TradeSmith | SponsoredLook at this $5 stock’s addressA small public company trading under $5 a share operates inside the secure perimeter of Kennedy Space Center, ...Freedom Financial | SponsoredA $382 trillion migration and the position no one is talking aboutTrump just signed a law requiring America's entire $382 trillion financial system to migrate to a new money ne...Awesomely | SponsoredSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...Altimetry | SponsoredThe REAL Reason Trump is Invading IranFor a moment… Forget about Trump’s ties to Israel. Forget about reports of Iran’s nuclear program. Be...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ARK Genomic Revolution ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share ARK Genomic Revolution ETF With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
